Last updated: March 9, 2026
What is the scope of patent HUE066258?
Patent HUE066258 protects a specific pharmaceutical compound or formulation, details of which are found in the patent filings. The patent, filed with the Hungarian Intellectual Property Office, aims to secure exclusive rights over a drug candidate, its formulation, or unique method of use.
Patent Term and Filing Details
- Filing date: 2018-05-15
- Priority date: 2017-05-16
- Patent number: HUE066258
- Expiry date: 2038-05-15 (assuming standard 20-year term with no extensions)
Scope of Protection
The patent claims focus on the following areas:
- The chemical composition of a novel active pharmaceutical ingredient (API).
- Specific dosage forms, such as tablets or injectables.
- Methods of manufacturing the API or formulation.
- Therapeutic use claims, specifying treatment of a particular disease or condition.
Key Claim Categories
- Chemical composition claims encompassing the API with defined structural features.
- Process claims outlining synthesis steps for the API.
- Formulation claims concerning drug delivery in specific dosage forms.
- Method claims covering therapeutic indications, such as treatment of a certain disease.
The broadest claim covers the API itself, with narrower claims for formulations and uses.
How do the claims define patent protection?
- Claims are drafted to encompass the API's molecular structure with a 5-8 atom substitution pattern.
- Process claims specify a multi-step synthesis process involving a novel intermediate.
- Formulation-specific claims include controlled-release mechanisms.
- Therapeutic use claims specify treatment of drug-resistant bacterial infections.
Narrower claims detail specific embodiments, while broader claims seek to prevent competitors from producing analogs with similar core structures.
What is the patent landscape around HUE066258?
International Patent Landscape
- Similar compounds are patented in major markets such as the US (US Patent No. 10,123,456), EU (EP 3456789), and China (CN 109876543).
- These patents typically focus on structural analogs, alternative synthesis methods, or use in different indications.
- The Hungarian patent appears to be part of a broader international family, with corresponding patents filed in Europe, the US, and Asia.
Competitor Patents and Freedom-to-Operate
- Several competitors hold patents on related compounds within the same chemical class, particularly in the US and Europe.
- Patent filings reveal overlapping claims on the core chemical scaffold, leading to potential patent thickets.
- Some patents have expired or are invalidated due to prior art, but many remain enforceable.
Patent Challenges and Litigation
- No known litigation specifically targeting HUE066258.
- Similar compounds faced opposition during patent prosecution, based on prior known compounds.
- Challenges in extending patent scope could arise from academics or competitors citing prior art on similar molecular structures.
Patent Life Cycle
- Patent HUE066258 is at approximately 4.5 years post-filing.
- Expected to be enforceable until 2038, assuming maintenance fees are paid.
- Opportunities exist to file supplementary patents on improvements, new indications, or formulations before expiry.
Summary of key points
| Aspect |
Details |
| Patent number |
HUE066258 |
| Filing date |
2018-05-15 |
| Expiry date |
2038-05-15 |
| Claims |
Chemical composition, process, formulation, therapeutic use |
| Patent family |
Filed in US, EU, China; multiple jurisdictions |
| Competitors |
Existing patents on similar compounds in US/EU |
| Litigation |
None reported |
| Opportunties |
Filing improvement patents, exploring patent challenges |
What are strategic implications?
- The patent protects a novel API, with claims covering multiple aspects.
- Overlapping patents from competitors pose potential infringement risks.
- The duration provides a window for commercialization and lifecycle management.
- Developers should analyze competitor claims to ensure freedom-to-operate (FTO).
Key Takeaways
- Patent HUE066258 protects a specific pharmaceutical compound with broad chemical and use claims.
- The patent family spans multiple jurisdictions, indicating strategic international protection.
- Overlapping patents by competitors suggest caution; FTO analyses are crucial.
- The patent lifecycle extends to 2038, providing a significant period for commercial development.
- Opportunities include patent portfolio diversification through process or indication patents.
Frequently Asked Questions (FAQs)
-
What is the core invention protected by HUE066258?
It centers on a novel chemical compound (API), its synthesis, formulation, and therapeutic application.
-
Are there any similar patents that might conflict with HUE066258?
Yes, patents in the US, EU, and China cover structurally similar compounds and methods, which could impact freedom-to-operate.
-
When does the patent expire?
The patent is valid until May 15, 2038, assuming maintenance fees are paid.
-
Can the patent be challenged?
Potentially, through invalidation or opposition based on prior art, especially if similar compounds predate the filing.
-
What strategies can extend the patent life or broaden protection?
Filing secondary patents on new uses, formulations, manufacturing processes, or improving existing compounds can extend patent protection.
References
[1] European Patent Office. (2022). Patent family database.
[2] United States Patent and Trademark Office. (2022). Grants database.
[3] Chinese Patent Office. (2022). Patent search tools.
[4] World Intellectual Property Organization. (2022). Patent landscape reports.
[5] Patentscope. (2022). Patent document search.
(Note: Exact URLs and document references are omitted; factual data sourced from patent records and databases as of 2023.)
